Canary Speech
Provo, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Canary Speech
161 people in our graph share verified history with the Canary Speech team — schools, employers, funds. One of them is your warm intro.
Glen Andersonunlockedknows Jeff Adams · together at University of California, Berkeley (overlapped)
×2knows the team · via Brigham Young University
×8knows the team · via University of California, Berkeley
knows the team · via Wabash College
Canary Speech develops vocal biomarker technology that analyzes voice to detect cognitive and behavioral conditions, providing clinicians, payers, and patients with decision-support signals on mood and cognitive status. Its API-first, HIPAA-compliant platform includes Canary Ambient, an ambient listening tool for preventive screening across healthcare settings, pharmaceutical trials, and call centers.
Founders & leadership
Canary Speech was founded in 2021 by Jeff Adams and Henry O'Connell.
JA
Jeff AdamsinChief Speech Officer, founderDirector at Canary Speech, which develops voice-based technology to detect cognitive and behavioral conditions for clinical decision support.
HO
Henry O'ConnellinCEO, President / FounderHenry O'Connell is CEO of Joined Bio, a company focused on connecting scientists with research data and biological samples. He previously founded iSpecimen, which works on access to biospecimens for research.
Board
RT
Ryan TidwellBoard director
PK
Peter KaanapuManager
JE
James EngebretsenManager
TP
Trent PerryManager
IV
Ivonne ValdesBoard director
WO
William O. PerryBoard director
Investors · 1
Also in the syndicate · 1
Cortes Capitallead
Reported raises · per SEC filings
Form D private placements$22.3M disclosed across 5 rounds · 2017–2024
▶$4.1MraisedJan 2025 · 9 investors · Other TechnologyRule 506(b)
▶$4.1MraisedJan 2025 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff AdamsDirector
- Ivonne ValdesDirector
- William O. PerryDirector
- Henry O'ConnellExecutive Officer, Director
- Ryan TidwellDirector
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$13MraisedJun 2024 · 60 investors · Other TechnologyRule 506(b)
▶$13MraisedJun 2024 · 60 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William O Perry IVDirector
- Ryan TidwallDirector
- Rick KreifeldtDirector
- Henry O'ConnellExecutive Officer, Director, Promoter
- Jeremy McFaddenExecutive Officer
- Jeff AdamsDirector
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.9MraisedMay 2023 · 12 investors · Other TechnologyRule 506(b)
▶$1.9MraisedMay 2023 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy McFaddenExecutive Officer
- Jeff AdamsDirector
- Rick KreifeldtDirector
- Trent PerryDirector
- David BearssDirector
- Henry O'ConnellExecutive Officer, Director, Promoter
- William O Perry IVDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.8MraisedMay 2022 · 2 investors · Other TechnologyRule 506(b)
▶$2.8MraisedMay 2022 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William O Perry IVDirector
- Henry O'ConnellExecutive Officer, Director, Promoter
- Jeff AdamsDirector
- Trent PerryDirector
- Jeremy McFaddenExecutive Officer
- David BearssDirector
- Rick KreifeldtDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$575KraisedAug 2017 · 4 investors · Other TechnologyRule 506(b)
▶$575KraisedAug 2017 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peter KaanapuExecutive Officer, Director
- Henry O'ConnellExecutive Officer, Director, Promoter
- James EngebretsenDirector
- Trent PerryDirector
- Jeff AdamsDirector
- Offering amount
- $2.5M
- Amount sold
- $575K
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Glass Health9 shared keywordsGlass Health provides an AI platform that assists clinicians in generating diagnostic hypotheses and developing treatment plans.
EvidenceCare9 shared keywordsEvidenceCare provides evidence-based clinical decision support tools integrated into electronic health records (EHRs) for physicians and health systems. The platform delivers curated clinical protocols and research to clinicians at the point of care to improve patient outcomes and optimize workflows.
Definitive Healthcare9 shared keywordsDefinitive Healthcare delivers market intelligence and data analytics on healthcare organizations, clinicians, and consumers, serving life sciences companies, healthcare providers, and other industries that interact with healthcare. The company provides data consolidation, analytics services, and digital advertising activation capabilities to help customers make informed decisions in the healthcare market.
Elion8 shared keywords
AVIA8 shared keywordsAVIA operates a network and advisory platform for health systems, providing benchmarking, market intelligence, and peer collaboration to support their digital transformation and AI adoption. It serves hospitals and health systems and includes offerings like AVIA Marketplace and Panda Health for evaluating digital health companies.
Foresee Medical7 shared keywordsForeSee Medical offers an AI-powered risk adjustment coding platform that integrates with electronic health records to identify, validate, and document chronic conditions in real time. It serves healthcare providers, health plans, and healthcare organizations to support accurate HCC coding, RAF score optimization, and CMS compliance in value-based care.
Companies competing with Canary Speech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Canary Speech do?
- Canary Speech develops vocal biomarker technology that analyzes voice to detect cognitive and behavioral conditions, providing clinicians, payers, and patients with decision-support signals on mood and cognitive status. Its API-first, HIPAA-compliant platform includes Canary Ambient, an ambient listening tool for preventive screening across healthcare settings, pharmaceutical trials, and call centers.
- Who founded Canary Speech?
- Canary Speech was founded by Jeff Adams, Henry O'Connell in 2021.
- How much funding has Canary Speech raised?
- Canary Speech has disclosed $22.3M raised across 5 rounds.
- Where is Canary Speech headquartered?
- Canary Speech is headquartered in Provo, US.